Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
AFYX Therapeutics
company
About
AFYX Therapeutics is a clinical stage biopharmaceutical company
- Copenhagen,Hovedstaden,Denmark
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €16.20M
- Industries
- Biotechnology,Clinical Trials,Delivery,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Also Known As
- Dermtreat ApS
AFYX Therapeutics is changing the way mucosal diseases are treated. They are a topical drug delivery company developing a pipeline of targeted treatments for conditions that currently lack approved therapy options. Their proprietary Rivelin® patch is flexible, biodegradable, and adhesive to mucosal surfaces. Designed with electrospinning technology, it delivers a therapeutic directly to the site in need, without interfering with patients’ daily activities.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€16.27M $13M
AFYX Therapeutics has raised a total of
€16.27M $13M
in funding over 2 rounds. Their latest funding was raised on
Jun 24, 2019 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 24, 2019 | Debt Financing | $13M | 2 | — | — | Detail |
| Jan 1, 2019 | Grant | €71.42K | 1 | — | — | Detail |
| May 9, 2017 | Series A | €16.20M | 3 |
Lundbeckfonden Emerge
Novo Holdings
Sofinnova Investments
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
4
AFYX Therapeutics is funded by 4 investors.
Sofinnova Investments
and Lundbeckfonden Emerge
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sofinnova Investments
|
Yes | Series A |
|
Lundbeckfonden Emerge
|
— | Debt Financing |
|
Novo Holdings
|
— | Debt Financing |
EASME - EU Executive Agency for SMEs
|
— | Grant |
Employee Profiles
Number of Employee Profiles
5
AFYX Therapeutics has 5 current employee profiles, including
Executive LARS SIIM MADSEN
Executive
Executive
Executive
Board member
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
